The effect of dexmedetomidine on nutrient organ blood flow

Anesthesia and Analgesia

Volumn 83, Issue 6, 1996, Pages 1160-1165

  Lawrence, C J ^a   Prinzen, F W ^a   De Lange, S ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTERIOVENOUS FISTULA; ARTICLE; BRAIN BLOOD FLOW; BRAIN OXYGEN CONSUMPTION; CONTROLLED STUDY; DOG; HEART OUTPUT; HEMODYNAMICS; KIDNEY BLOOD FLOW; NONHUMAN; ORGAN BLOOD FLOW; ORGAN PERFUSION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SKIN BLOOD FLOW; VENOUS OXYGEN TENSION;

EID: 0029905855     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199612000-00005     Document Type: Article

References (25)

1. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605.
2. Lawrence CJ, Prinzen FW, de Lange S. The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand. Anesth Analg 1996;82:544-50.
3. Roekaerts PM, Willigers HMM, Prinzen FW, de Lange S. The effects of alpha2-adrenergic stimulation with mivazerol on myocardial blood flow and function during coronary artery stenosis in anesthetized dogs. Anesth Analg 1996;82:702-11.
4. Roekaerts PMHJ, Prinzen FW, de Lange S. Coronary vascular effects of dexmedetomidine during reactive hyperemia in the anesthetized dog. J Cardiothorac Vase Anesth 1996;10:619-26.
5. Flacke WE, Flacke JW, Bloor BC, et al. Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog. J Cardiothorac Vase Anesth 1993;7:41-9.
6. Proctor LT, Schmeling WT, Roerig D, et al. Oral dexmedetomidine attenuates hemodynamic responses during emergence from general anesthesia in chronically instrumented dogs. Anesthesiology 1991;74:108-14.
7. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992;77:1134-42.
8. Heymann MA, Payne BD, Hoffman JIE, Rudolph AM. Blood flow measurements with radionuclide-labeled microspheres. Prog Cardiovasc Dis 1977;20:55-79.
9. Prinzen FW, van der Vusse GJ, Reneman RS. Blood flow distribution in the left ventricular free wall in open-chest dogs. Basic Res Cardiol 1981;76:431-7.
10. Maggi CA, Meli A. Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 1: General considerations. Experientia 1986;42:109-14.
11. Wollman H, Alexander SC, Cohen PJ, et al. Cerebral circulation of man during halothane anesthesia: effects of hypocarbia and d-tubocurarine. Anesthesiology 1964;25:180-4.
12. Haberer JP, Audibert G, Saunier CG, et al. Effect of propofol and thiopentone on regional blood flow in brain and peripheral tissues during normoxia and hypoxia in the dog. Clin Physiol 1993;13:197-207.
13. Zornow MH, Fleischer JE, Scheller MS, et al. Dexmedetomidine, J an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth Analg 1990;70:624-30.
14. Karlsson BR, Forsman M, Roald OK, et al. Effect of dexmedetomidine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs [comments]. Anesth Analg 1990;71:125-9.
15. de Leeuw PW, van Es PN, de Bos R, Birkenhager WH. Role of alpha 1- and alpha 2-adrenergic receptors in the human hypertensive kidney. Hypertension 1987;9:1210-2.
16. Coffman JD, Cohen RA. Role of alpha-adrenoceptor subtypes mediating sympathetic vasoconstriction in human digits. Eur J Clin Invest 1988;18:309-13.
17. Baker CH, Davis DL, Sutton ET. Blood flow distribution with adrenergic and histaminergic antagonists. Proc Soc Exp Biol Med 1989;190:260-7.
18. Daemen MJAP, Thijssen HHW, Essen Hv, et al. Liver blood flow measurement in the rat. The electromagnetic versus the micro-sphere and the clearance methods. J Pharmacol Methods 1989;21:287-97.
19. Lang RM, Marcus RH, Neumann A, et al. A time-course study of the effects of pentobarbital, fentanyl, and morphine chloralose on myocardial mechanics. J Appl Physiol 1992;73:143-50.
20. Maggi CA, Meli A. Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 2: Cardiovascular system. Experientia 1986;42:292-7.
21. Seagard JL, Hopp FA, Donegan JH, et al. Halothane and the carotid sinus reflex: evidence for multiple sites of action. Anesthesiology 1982;57:191-202.
22. Trigt Pv, Christian CC, Fagraeus L, et al. Myocardial depression by anesthetic agents (halothane, enflurane and nitrous oxide): quantitation based on end-systolic pressure-dimension relations. Am J Cardiol 1984;53:243-7.
23. Wilkinson PL, Tyberg JV, Moyers JR, White AE. Correlates of myocardial oxygen consumption when afterload changes during halothane anesthesia in dogs. Anesth Analg 1980;59:233-9.
24. Inoue K, Samodelor LF, Arndt JO. Fentanyl activates a particular population of vagal efferents which are cardioinhibitory. Naunyn-Schmiedebergs Arch Pharmacol 1980;312:57-61.
25. Laubie M, Schmitt H, Drouillat M. Central sites and mechanisms of the hypotensive and bradycardic effects of the narcotic analgesic agent fentanyl. Naunyn-Schmiedebergs Arch Pharmacol 1977;296:255-61.